Waddell & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$424K Buy
4,627
+2,253
+95% +$197K 0.02% 306
2026
Q1
$202K Buy
+2,374
New +$212K 0.01% 423
2025
Q4
Sell
-3,763
Closed -$301K 386
2025
Q3
$301K Buy
3,763
+163
+5% +$13.9K 0.03% 214
2025
Q2
$327K Sell
3,600
-3,556
-50% -$325K 0.03% 156
2025
Q1
$671K Sell
7,156
-1,200
-14% -$107K 0.08% 64
2024
Q4
$760K Hold
8,356
0.08% 62
2024
Q3
$867K Hold
8,356
0.11% 58
2024
Q2
$811K Hold
8,356
0.11% 57
2024
Q1
$752K Hold
8,356
0.1% 61
2023
Q4
$666K Sell
8,356
-244
-3% -$18.3K 0.09% 63
2023
Q3
$612K Hold
8,600
0.09% 69
2023
Q2
$663K Sell
8,600
-21
-0.2% -$1.63K 0.1% 62
2023
Q1
$648K Hold
8,621
0.1% 63
2022
Q4
$679K Buy
8,621
+21
+0.2% +$1.57K 0.11% 61
2022
Q3
$604K Hold
8,600
0.12% 56
2022
Q2
$689K Hold
8,600
0.14% 54
2022
Q1
$652K Hold
8,600
0.1% 54
2021
Q4
$734K Hold
8,600
0.12% 51
2021
Q3
$650K Hold
8,600
0.11% 52
2021
Q2
$700 Buy
+8,600
New +$703K 0.11% 50

Other funds holding CL

Waddell & Associates's CL Position: Q2 2026 in Review

Waddell & Associates increased its Colgate-Palmolive (CL) stake by 95% in Q2 2026, buying an estimated $197K and bringing the position to 4,627 shares worth $424K. The position accounts for 0.02% of the portfolio, ranked #306.

Waddell & Associates first reported a position in CL in Q2 2021 and has held it in 20 quarters since. The position peaked at $867K in Q3 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Waddell & Associates held 4,627 shares of Colgate-Palmolive worth $424K as of Q2 2026.
  • Waddell & Associates bought 2,253 Colgate-Palmolive shares in Q2 2026, an estimated $197K.
  • Colgate-Palmolive made up 0.02% of Waddell & Associates's portfolio in Q2 2026, its #306 holding.
  • Waddell & Associates first reported a position in Colgate-Palmolive in Q2 2021 and has held it in 20 quarters since.
  • Waddell & Associates's Colgate-Palmolive position peaked at $867K in Q3 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.